Emily Lopez

Emily Lopez is a Senior Manager of Clinical Communications at Vaniam Group since April 2023, previously serving as an Analyst at ClearView Healthcare Partners from August 2021 to February 2023, where Emily developed marketing strategies and customer engagement models for leading pharmaceutical companies. Emily's earlier experience includes research roles at Broad Institute of MIT and Harvard, where an honors thesis focused on Ebola virus disease progression, and contributions to projects at AbbVie and Beth Israel Deaconess Medical Center related to blood brain barrier transporters and type II diabetes genetics. Emily holds a Bachelor of Arts in Cell/Cellular and Molecular Biology from Harvard University, awarded in 2021.